Physician profile

Ramoun D Jones

Interventional Pain Medicine · Phoenix, AZ

NPI 1508898602

$51,309.26

in general payments reported to CMS, 2019-2025

36 companies · $1,514 in 2025

The $1,514 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).

See the full distribution for Interventional Pain Medicine

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$10,592.50
Food and Beverage$10,068.57
Education$1,120.98
Travel and Lodging$559.04
Entertainment$49.99

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Painteq LLC $13,671.79 2021-2024 Painteq
Abbott Laboratories $7,220.42 2019-2025 Proclaim, Eterna, Octrode
Foundation Fusion Solutions, LLC $6,447.13 2020-2024
Aurora Spine, INC. $5,500.00 2024 Silo Tfx
Boston Scientific Corporation $4,474.28 2019-2025 Wavewriter Alpha Prime 16, General - Pain Management, Superion Indirect Decompression System
Vertos Medical, INC. $3,925.73 2019-2024 Mild Device Kit
Nevro Corp. $1,643.41 2019-2023 Senza
Impactortho, INC. $1,612.39 2020
Spinal Simplicity, LLC $1,265.94 2020-2024 Ha Minuteman G3-R, Liberty Si
Nalu Medical, INC. $823.08 2021-2024 Nalu Neurostimulation System
Vertiflex, INC. $641.63 2019
Goode Surgical INC $580.12 2020
Spinefrontier, INC. $512.31 2024-2025 Sijfuse, Inspan, Nanofuse
Biotronik Nro, INC. $409.44 2024-2025 Prospera
Relievant Medsystems, INC. $400.38 2019-2023 Intracept
Show all 36 companies
CompanyGeneral paymentsYearsTop products
Curonix LLC $278.55 2023-2025 Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A
Medtronic USA, INC. $272.36 2019
Spr Therapeutics, INC $270.96 2019-2025 Sprint Pns System
Abbvie INC. $206.70 2021-2025
Stimwave Technologies Incorporated $180.43 2019
Stratus Medical, LLC $179.95 2021
Nuvasive, INC. $140.49 2022
Acacia Pharma INC $120.60 2021
Saluda Medical Americas, INC. $110.18 2023 Evoke Scs
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $77.77 2019-2021
Flowonix Medical Incorporated $74.54 2019-2020
Amgen INC. $43.95 2020-2021
Protega Pharmaceutials INC $43.63 2025 Roxybond
Hikma Pharmaceuticals USA $42.00 2022
Allergan, INC. $41.47 2021-2022
Almatica Pharma LLC $24.16 2021
Scilex Pharmaceuticals INC. $17.83 2021
Radius Health, INC. $17.31 2021
Sentynl Therapeutics, INC. $14.01 2019
Daiichi Sankyo INC. $12.81 2019
Collegium Pharmaceutical, INC. $11.51 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Ramoun D Jones

$51,309.26

in general payments reported 2019-2025

Years
2019-2025
Top company
Painteq LLC
Context
The $1,514 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).

https://glasscript.com/doctor/204121/ramoun-d-jones

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Download CSV

The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.